AAAAAA
Results:
1-8
|
Results: 8
Authors:
Genvresse, I
Lange, C
Schanz, J
Schweigert, M
Harder, H
Possinger, K
Spath-Schwalbe, E
Citation: I. Genvresse et al., Tolerability of the cytoprotective agent amifostine in elderly patients receiving chemotherapy: a comparative study, ANTI-CANC D, 12(4), 2001, pp. 345-349
Authors:
Genvresse, I
Wedding, U
Bokemeyer, C
Spath-Schwalbe, E
Citation: I. Genvresse et al., Treatment of multiple myeloma in the elderly: Consensus of the cooperativegroup of geriatric oncology of the DGHO and DGG, ONKOLOGIE, 24(4), 2001, pp. 386-390
Authors:
Spath-Schwalbe, E
Genvresse, I
Koschuth, A
Dietzmann, A
Grunewald, R
Possinger, K
Citation: E. Spath-schwalbe et al., Phase II trial of gemcitabine in patients with pretreated advanced soft tissue sarcomas, ANTI-CANC D, 11(5), 2000, pp. 325-329
Authors:
Genvresse, I
Spath-Schwalbe, E
Meisel, H
Kaufmann, O
Kruger, DH
Possinger, K
Citation: I. Genvresse et al., Primary hepatic or splenic diffuse large B-cell lymphoma and hepatitis C virus infection: a non-fortuitous association?, ANN HEMATOL, 79(9), 2000, pp. 530-532
Authors:
Genvresse, I
Buttgereit, F
Spath-Schwalbe, E
Ziemer, S
Eucker, J
Possinger, K
Citation: I. Genvresse et al., Arterial thrombosis associated with anticardiolipin and anti-beta 2-glycoprotein-I antibodies in patients with non-Hodgkin's lymphoma: a report of two cases, EUR J HAEMA, 65(5), 2000, pp. 344-347
Authors:
Genvresse, I
Flath, B
Akrivakis, K
Beinert, T
Spath-Schwalbe, E
Possinger, K
Citation: I. Genvresse et al., Resolution of psoriatic skin lesions after chemotherapy with gemcitabine and vinorelbine, BR J DERM, 143(6), 2000, pp. 1326-1327
Authors:
Spath-Schwalbe, E
Genvresse, I
Stein, H
Gelderblom, H
Lehmann, R
Budach, V
Possinger, K
Citation: E. Spath-schwalbe et al., Highly malignant primary Burkitt-type B-cell lymphoma, DEUT MED WO, 124(15), 1999, pp. 451-455
Authors:
Genvresse, I
Dietzmann, A
Massenkeil, G
Spath-Schwalbe, E
Possinger, K
Citation: I. Genvresse et al., Subacute encephalopathy after combination chemotherapy including moderate-dose methotrexate in a patient with gastric cancer, ANTI-CANC D, 10(3), 1999, pp. 293-294
Risultati:
1-8
|